Company intelligence / Profile preview

Mid-Link Technology Testing

Tianjin, Tianjin Shi, China

Ownership: Private
Employees: ~101
Development stage: Other

Overview

Mid-Link Technology Testing is a prominent China-based CRO and consulting firm specializing in medical device and pharmaceutical regulatory testing. The company offers a wide portfolio including bench testing, preclinical animal studies, quality audits, and registration services globally. However, as of 2024-2025, the FDA has rejected all data from this facility due to serious, unresolved allegations of falsified and unreliable test data in biocompatibility and animal safety studies, resulting in a suspension of acceptance for all device or drug-related test data submitted to the FDA from this facility.

Modalities: Medical DevicesPharmaceuticals
Industry: Contract Research Organization

Beyond the preview

Go deeper on Mid-Link Technology Testing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mid-Link Technology Testing.

Explore the full profile